Literature DB >> 3947551

The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells.

U Galili, I Flechner, A Knyszynski, D Danon, E A Rachmilewitz.   

Abstract

A highly sensitive antiglobulin test based on rosette formation due to the interaction between IgG bearing red blood cells (RBC) and Fc receptors on K562 cells, was used to study the immunoglobulin molecules present on human senescent RBC. Normal human RBC were separated into young and senescent subpopulations on the basis of age-dependent differences in density by centrifugation on a discontinuous density Percoll gradient, and by flotation on phthalate ester mixtures. The senescent but not the young RBC were found to bear membrane bound IgG. Most of the bound IgG molecules could be specifically eluted by galactose in its alpha-anomeric form. Antigalactosyl (anti-Gal) IgG antibodies with similar reactivity were found to be present in high titres in every one of the 400 normal human sera tested. The natural anti-Gal antibodies isolated from normal sera by affinity chromatography could bind to IgG depleted senescent RBC but not to young RBC. Erythrophagocytosis experiments indicated that the anti-Gal bound to the senescent RBC induced their destruction by macrophages. It is suggested that the natural anti-Gal antibodies interact with cryptic alpha-galactosyl residues which are exposed in the course of the RBC senescence and mediate the removal of these RBC from circulation by cells of the reticuloendothelial system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947551     DOI: 10.1111/j.1365-2141.1986.tb02935.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  20 in total

1.  Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues.

Authors:  P B Yu; W Parker; M L Everett; I J Fox; J L Platt
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipids.

Authors:  A Kalisiak; E Oosterwijk; J G Minniti; L J Old; D A Scheinberg
Journal:  Glycoconj J       Date:  1991-02       Impact factor: 2.916

3.  Localization of binding sites of Ulex europaeus I, Helix pomatia and Griffonia simplicifolia I-B4 lectins and analysis of their backbone structures by several glycosidases and poly-N-acetyllactosamine-specific lectins in human breast carcinomas.

Authors:  N Ito; S Imai; S Haga; C Nagaike; Y Morimura; K Hatake
Journal:  Histochem Cell Biol       Date:  1996-09       Impact factor: 4.304

4.  Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies.

Authors:  J D Corbett; D E Golan
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

5.  Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing.

Authors:  R M Hamadeh; M M Estabrook; P Zhou; G A Jarvis; J M Griffiss
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 6.  Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.

Authors:  U Galili
Journal:  Springer Semin Immunopathol       Date:  1993

Review 7.  Measurement of posttransfusion red cell survival with the biotin label.

Authors:  Donald M Mock; John A Widness; Peter Veng-Pedersen; Ronald G Strauss; Jose A Cancelas; Robert M Cohen; Christopher J Lindsell; Robert S Franco
Journal:  Transfus Med Rev       Date:  2014-04-05

Review 8.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07

9.  Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora.

Authors:  U Galili; R E Mandrell; R M Hamadeh; S B Shohet; J M Griffiss
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

10.  Bacterial enzymes can add galactose alpha 1,3 to human erythrocytes and creates a senescence-associated epitope.

Authors:  R M Hamadeh; G A Jarvis; P Zhou; A C Cotleur; J M Griffiss
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.